Blood Transfusion and Erythropoietin
Links shared publicly online about this topic
Erythropoietin
marvistavet.com — “Erythropoietin” View full resource at marvistavet.com
Most Recently Shared on November 8, 2009 at 12:28 am By:
anemic Zabor, with chronic renal failure & developed antibodies to erythropoietin http://bit.ly/14Zg42 receives 5 units of packed-cell blood
Erythropoietin - VeterinaryPartner.com - a VIN company!
veterinarypartner.com — “Erythropoietin - VeterinaryPartner.com - a VIN company!” View full resource at veterinarypartner.com
Most Recently Shared on April 16, 2010 at 6:50 pm By:
began blood transfusion for Zabor; chronic renal failure, erythropoietin no longer an option http://bit.ly/aUJl6k
Erythropoietin May Pose A Risk To Blood Vessels In The Brain And Body
medicalnewstoday.com — “Erythropoietin May Pose A Risk To Blood Vessels In The Brain And Body” View full resource at medicalnewstoday.com
Most Recently Shared on December 13, 2011 at 8:05 am By:
Erythropoietin May Pose A Risk To Blood Vessels In The Brain And Body http://t.co/KUNzR4Xz #sportsmedicine
Blood Transfusions
kidshealth.org — “A blood transfusion is a safe and relatively simple medical procedure that replaces blood lost during surgery or because of an injury or illness.” View full resource at kidshealth.org
Most Recently Shared on August 5, 2009 at 5:06 pm By:
Blood Transfusions
kidshealth.org — “More than 5 million people a year get blood transfusions in the United States. This article for teens explains why people need them and who donates the blood used.” View full resource at kidshealth.org
Most Recently Shared on January 28, 2011 at 7:30 pm By:
Erythropoietin Counteracts Breast Cancer Treatment with Herceptin
newswise.com — “Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.” View full resource at newswise.com
Most Recently Shared on November 15, 2010 at 9:35 pm By:
Erythropoietin Counteracts Breast Cancer Treatment with Herceptin: Red-blood-cell-boosting drugs used to treat a... http://bit.ly/c45KUW
Erythropoietin counteracts breast cancer treatment with herceptin
physorg.com — “Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.” View full resource at physorg.com
Most Recently Shared on November 15, 2010 at 9:50 pm By:
Erythropoietin counteracts breast cancer treatment with herceptin http://bit.ly/bsbAIO
ArmaGen® Re-engineers Erythropoietin For Brain Penetration
medicalnewstoday.com — “Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development fo” View full resource at medicalnewstoday.com
Most Recently Shared on July 17, 2010 at 2:04 pm By:
ArmaGen® Re-engineers Erythropoietin For Brain Penetration http://mnt.to/3Gfn #pharma #pharmaceutical
Study Examines Blood Biomarkers Upon Erythropoietin Treatment of Ischemic Stroke | Biomarker Commons
biomarkercommons.org — “Researchers at the Max Planck Institute of Experimental Medicine in Goettingen, Germany, led by Prof. Hannelore Ehrenreich, the University of Bremen and University of Hannover, in collaboration with Dr.” View full resource at biomarkercommons.org
Most Recently Shared on September 29, 2011 at 4:45 pm By:
Allergy/Immunology News & Articles - MDLinx - Erythropoietin on #MDlinx
mdlinx.com — “Allergy/Immunology News & Articles - MDLinx - Erythropoietin on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 14, 2010 at 6:05 am By:
Erythropoietin Receptor Is Expressed on Human Peripheral Blood T and B Lymphocytes and Monocytes and Is... http://bit.ly/9xD0Qw #AI #mdlinx
Administration of erythropoietin to patients with heart attack who undergo coronary intervention procedures
sciencedaily.com — “Intravenous administration of epoetin alfa, a product that stimulates red blood cell production, to patients with heart attack who were undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), did not provide reduction in the size of the heart muscle involved and was associated with higher rates of adverse cardiovascular events, according to a new study.” View full resource at sciencedaily.com
Most Recently Shared on May 10, 2011 at 10:53 pm By:
ScienceDaily: Administration of erythropoietin to patients with heart attack who undergo: http://bit.ly/irzqO7 Full http://bit.ly/lsfv7k
Study examines outcomes of erythropoietin use for heart attack patients undergoing PCI
eurekalert.org — “Intravenous administration of epoetin alfa, a product that stimulates red blood cell production, to patients with heart attack who were undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), did not provide reduction in the size of the heart muscle involved and was associated with higher rates of adverse cardiovascular events, according to a study in the May 11 issue of JAMA.” View full resource at eurekalert.org
Most Recently Shared on May 11, 2011 at 12:27 am By:
HDCN: Giving EPO to heart attack patients receiving PCI linked to increased infarct size. http://bit.ly/lu4BIU
Hospira Begins Phase I U.S. Clinical Trial Of Biosimilar Erythropoietin In Renal Patients
medicalnewstoday.com — “Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with rena” View full resource at medicalnewstoday.com
Most Recently Shared on July 28, 2010 at 10:04 pm By:
Hospira Begins Phase I U.S. Clinical Trial Of Biosimilar Erythropoietin In Renal Patients Hospira, Inc. (NYSE: HSP), th.. http://dld.bz/pfYy
Blood Transfusion-Overview
webmd.com — “What is a blood transfusion?Blood transfusion is a medical treatment to replace blood or portions of the blood lost through injury, surgery, or disease.When is a blood transfusion needed?A blood transfusion is needed if you have had significant blood loss or if your body cannot make or is losing an important component of blood.Blood may be lost through:Injury or major surgery.An illness that ...” View full resource at webmd.com
Most Recently Shared on July 24, 2010 at 9:43 pm By:
Zsa Zsa Gabor remains critical after a blood transfusion. We wish her well. http://bit.ly/cJwsKU
Medical News: No Reduction in Transfusions with ESAs - in Hematology/Oncology, Hematology from MedPage Today
medpagetoday.com — “Widespread use of erythropoiesis-stimulating agents among cancer patients undergoing chemotherapy has not resulted in the expected decrease in the rate of blood transfusions, a large retrospective coh” View full resource at medpagetoday.com
Most Recently Shared on November 11, 2009 at 1:02 pm By:
Erythropoiesis-stimulating agents don't reduce the need for blood transfusions in cancer patients. More: http://bit.ly/2xp70o
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Newport Beach Vet
Welcome to The Newport Beach Veterinary Hospital. General DVM & Internal Medicine Specialist Veterinarian helping dogs & cats of Orange County, California.
-
Newport Beach Vet
Welcome to The Newport Beach Veterinary Hospital. General DVM & Internal Medicine Specialist Veterinarian helping dogs & cats of Orange County, California.
-
MNT Sports Medicine
The latest sports medicine news published daily. Articles from research centers, universities and prestigious journals.
Advertisement

